Stock listing

NASDAQ:MNOV MediciNova, Inc. Stock

Home listing (NASDAQ) of MediciNova, Inc.

Follow MediciNova, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:MNOV

$1.31 USD -0.02 (-1.5%)

Close on Nov 20, 2026

Past year -7.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.27 – $1.31 USDNov 20, 2026
Volume
48,972 sharesNov 20, 2026
Market cap
$67.11M USDAt the close on Nov 20, 2026 · price × 51.23M shares outstanding
52-week range
$1.22 – $3.90 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$900,525 USDMedian day 69,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
MediciNova, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MNOV · Home$1.31 USD-0.02 (-1.5%)48,972$1.27$1.31$1.27$1.33Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MNOV · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.31-0.02-1.5%$1.27$1.31$1.2748,972
$1.33-0.01-0.7%$1.32$1.41$1.26115,567
$1.340.000.0%$1.375$1.39$1.3257,887
$1.34-0.055-3.9%$1.381$1.41$1.3495,443
$1.395-0.005-0.4%$1.40$1.445$1.3961,649
$1.40-0.01-0.7%$1.40$1.42$1.4012,072
$1.41+0.01+0.7%$1.43$1.43$1.4018,854
$1.40-0.07-4.8%$1.548$1.548$1.4065,001
$1.47+0.01+0.7%$1.46$1.47$1.42154,523
$1.46+0.01+0.7%$1.47$1.48$1.4414,229
$1.450.000.0%$1.45$1.47$1.45139,459
$1.45+0.03+2.1%$1.44$1.538$1.4350,037
$1.42-0.02-1.4%$1.43$1.49$1.4156,684
$1.44+0.04+2.9%$1.40$1.53$1.4047,866
$1.400.000.0%$1.42$1.42$1.3829,658
$1.40-0.07-4.8%$1.46$1.50$1.3952,996
$1.47+0.06+4.3%$1.42$1.49$1.40125,005
$1.41+0.01+0.7%$1.42$1.42$1.3937,749
$1.40+0.01+0.7%$1.42$1.47$1.4089,906
$1.39-0.02-1.4%$1.40$1.42$1.3925,300
$1.410.000.0%$1.41$1.42$1.3830,500
$1.41+0.05+3.7%$1.37$1.41$1.3731,500
$1.36-0.04-2.9%$1.40$1.44$1.3637,100
$1.40-0.02-1.4%$1.40$1.45$1.37144,200
$1.42-0.03-2.1%$1.47$1.50$1.4280,200
$1.45-0.02-1.4%$1.47$1.53$1.4558,800
$1.47-0.03-2.0%$1.51$1.55$1.4696,200
$1.50-0.04-2.6%$1.56$1.56$1.5034,800
$1.54+0.02+1.3%$1.49$1.58$1.48127,800
$1.52-0.02-1.3%$1.54$1.57$1.5269,900
$1.54-0.07-4.3%$1.60$1.61$1.53109,400
$1.61-0.04-2.4%$1.65$1.68$1.6078,000
$1.65-0.11-6.3%$1.72$1.72$1.65120,000
$1.76-0.02-1.1%$1.87$1.89$1.74212,900
$1.78+0.15+9.2%$1.67$1.84$1.67274,500
$1.63-0.05-3.0%$1.69$1.72$1.63263,200
$1.68-0.24-12.5%$1.86$1.86$1.66369,800
$1.92-0.18-8.6%$2.05$2.07$1.77595,100
$2.10-0.48-18.6%$2.40$2.45$1.691,617,500
$2.58-0.07-2.6%$2.68$2.69$2.53251,900
$2.65-0.15-5.4%$2.67$2.67$2.48452,800
$2.80-0.10-3.4%$2.90$3.02$2.75395,800
$2.90-0.40-12.1%$3.16$3.30$2.902,474,200
$3.30-0.02-0.6%$3.28$3.40$3.03666,900
$3.32-0.13-3.8%$3.20$3.62$2.721,634,400
$3.45+0.93+36.9%$2.84$3.90$2.837,413,200
$2.52+0.50+24.8%$2.16$2.62$2.151,420,800
$2.02+0.15+8.0%$1.94$2.07$1.93207,100
$1.87+0.06+3.3%$1.91$1.92$1.8768,500
$1.81+0.07+4.0%$1.73$1.84$1.7345,900
$1.74-0.05-2.8%$1.78$1.78$1.7267,800
$1.79+0.04+2.3%$1.82$1.85$1.75106,200
$1.75+0.12+7.4%$1.67$1.76$1.65137,800
$1.63+0.01+0.6%$1.62$1.63$1.5596,700
$1.62+0.19+13.3%$1.45$1.63$1.45111,300
$1.43-0.01-0.7%$1.44$1.46$1.4314,300
$1.440.000.0%$1.46$1.46$1.4220,000
$1.440.000.0%$1.43$1.46$1.4318,700
$1.44+0.02+1.4%$1.42$1.45$1.4216,900
$1.42-0.06-4.1%$1.49$1.52$1.4225,400
$1.48-0.09-5.7%$1.57$1.58$1.4340,700
$1.57+0.04+2.6%$1.55$1.58$1.4887,127
$1.53+0.14+10.1%$1.39$1.54$1.39118,900
$1.39+0.02+1.5%$1.38$1.40$1.3726,000
$1.37-0.01-0.7%$1.38$1.38$1.3324,400

Splits

1 split · NASDAQ:MNOV · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
NASDAQ:MNOV
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All MediciNova, Inc. news

MediciNova, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
17 in the last 12 months · 144 in all · newest Oct 12, 2026 · oldest 2019
Decks
33 decks · latest Nov 13, 2026

Where MediciNova, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MNOV · Home listing · This pageNASDAQUnited StatesUSD
Tokyo:4875 メディシノバ・インクTokyoJapanJPY
BOATS:MNOVBOATSUnited StatesUSD

Valuation

EV/sales 41.1× against a median of 12.4×: 4th lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$38.45M USD
P/E
Loss
EV/sales
41.1×
EV/EBITDA
Negative EBITDA
Price/book
1.6×
Gross margin
46.8%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
0.56

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
MediciNova, Inc. · NASDAQ:MNOVUS$67.11MUS$38.45Mn/a41.1×n/a1.6×n/a0.0×0.56
MAIA Biotechnology, Inc. · AMEX:MAIAUS$68.54MUS$68.54Mn/an/an/a4.7×n/a0.0×1.62
ABIONYX Pharma SA · EURONEXT:ABNXUS$68.36MUS$55.53Mn/a12.4×n/a4.0×−136.6%1.0×n/a
Cingulate Inc. · NASDAQ:CINGUS$67.48MUS$1.21Bn/an/an/a3.3×n/a56.0×1.41
Energenesis Biomedical Co., Ltd. · TWSE:6657US$67.22MUS$47.02Mn/a203×n/a3.1×n/a0.0×n/a
Dicot Pharma AB · OMXSTO:DICOTUS$66.56MUS$44.51Mn/an/an/a3.0×n/a0.0×n/a
Cardiff Oncology, Inc. · NASDAQ:CRDFUS$66.34MUS$32.82Mn/a58.7×n/a2.4×n/a0.0×1.32
Polaryx Therapeutics, Inc. · NASDAQ:PLYXUS$66.30MUS$57.86Mn/an/an/a8.7×n/a0.0×1.66
PMV Pharmaceuticals, Inc. · NASDAQ:PMVPUS$66.17M−US$36.25Mn/an/an/a1.2×n/a0.0×1.43
Gossamer Bio, Inc. · NASDAQ:GOSSUS$65.57MUS$55.23Mn/a0.7×n/an/a−159.5%n/a1.56
Tenaya Therapeutics, Inc. · NASDAQ:TNYAUS$65.32MUS$1.38Mn/a0.5×n/a1.2×n/a0.1×2.42
Median of the othersUS$66.45MUS$51.12M12.4×3.1×−148.0%0.0×1.56

Forecasts

3 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
8.25 USD · Analysts' mean
EPS, year to Dec 2026
-0.26 · 3 analysts
Revenue, year to Dec 2026
730K · 3 analysts

Team and board

Officers

OfficerRole
Yuichi IwakiExecutive Chairman of the Board, President and Chief Executive Officer, Founder
Kazuko MatsudaMember of the Board of Directors, Senior Vice President, Chief Medical Officer, Representative, Tokyo Office

Board

DirectorRole
Yuichi IwakiExecutive Chairman of the Board, President and Chief Executive Officer, Founder

Events

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close−0.4%
Q2 2026Aug 13, 2026 · After close0.0%
Q1 2026May 14, 2026 · After close−1.4%
Q4 2025Feb 20, 2026 · Before open−3.2%
Q3 2025Nov 12, 2025 · After close−1.9%
Q2 2025Aug 14, 2025 · After close+0.8%
Q1 2025May 13, 2025 · After close−6.2%
Q4 2024Feb 19, 2025 · After close−9.9%
Q3 2024Nov 13, 2024 · After close−8.8%
Q2 2024Aug 8, 2024 · After close+0.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close+4.8%
Q4 2023Feb 15, 2024 · After close+0.7%
Q3 2023Nov 9, 2023 · After close−0.6%
Q2 2023Aug 9, 2023 · After close+1.7%
Q1 2023May 11, 2023 · After close0.0%
Q4 2022Feb 16, 2023 · After close+2.6%
Q3 2022Nov 10, 2022 · After close−0.9%
Q2 2022Aug 11, 2022 · After close+2.0%
Q1 2022May 12, 2022 · After close+1.7%
Q4 2021Feb 16, 2022 · After close−3.5%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings20 slidesNov 13, 2026
Q2 2026 Earnings PresentationEarnings31 slidesSep 11, 2026
Investor Presentation (May 2026)Investor deck25 slidesMay 2026
Investor Presentation (March 2025)Investor deck17 slidesMarch 2025
International Symposium on ALS/MND 2018Conference35 slidesDecember 2018
Technical Presentation (2018)Technical18 slides2018
International Symposium on ALS/MND 2017Conference44 slides2017
Technical Presentation (2017)Technical20 slides2017
Investor Presentation (November 2016)Investor deck36 slidesNov 10, 2016
Investor Presentation (September 2015)Investor deck21 slidesSep 25, 2015
All 33 decks
DeckKindSlidesDate
Investor Presentation (October 2014)Investor deck18 slidesOct 17, 2014
Investor Presentation (July 2013)Investor deck32 slidesJul 17, 2013
Investor Presentation (July 2012)Investor deck57 slidesJul 5, 2012
Investor Presentation (February 2012)Investor deck47 slidesFeb 15, 2012
Investor Presentation (February 2011)Investor deck42 slidesFeb 7, 2011
Investor Presentation (January 2011)Investor deck19 slidesJan 7, 2011
Investor Presentation (October 2010)Investor deck9 slidesOct 4, 2010
Investor Presentation (September 2010)Investor deck14 slidesSep 14, 2010
Investor Presentation (March 2010)Investor deck25 slidesMar 18, 2010
Investor Presentation (March 2010)Investor deck27 slidesMar 9, 2010
Investor Presentation (January 2010)Investor deck29 slidesJan 11, 2010
Merger or Acquisition (November 2009)Merger or acquisition27 slidesNov 17, 2009
Merger or Acquisition (September 2009)Merger or acquisition48 slidesSep 4, 2009
Investor Presentation (January 2009)Investor deck36 slidesJan 12, 2009
Investor Presentation (November 2008)Investor deck34 slidesNov 10, 2008
Technical Presentation (June 2008)Technical14 slidesJun 25, 2008
Investor Presentation (April 2008)Investor deck28 slidesApr 29, 2008
Investor Presentation (January 2008)Investor deck27 slidesJan 7, 2008
Investor Presentation (October 2007)Investor deck22 slidesOct 10, 2007
Investor Presentation (September 2007)Investor deck20 slidesSep 26, 2007
Investor Presentation (July 2007)Investor deck33 slidesJul 24, 2007
Investor Presentation (May 2007)Investor deck30 slidesMay 30, 2007
Investor Presentation (March 2007)Investor deck24 slidesMar 30, 2007

Open Decks

Financings

RaiseDate
Common stock
Announced: raise
Buyers: YAII PN, Ltd (Yorkville Advisors Global LP) (Committed to buy up to $30 million worth of common stock over 36 months at 97% of the market price, at the Company's discretion)
Use of proceeds: To further advance R&D programs and for general corporate activities
Jul 31, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$3.88 a share on Jan 31, 2005.

Price
US$3.88 a share
Shares offered
30,000,000 shares of common stock
Offering size
US$116.4 million
Underwriter
Daiwa Securities SMBC
Shares delivered
On or about Feb 7, 2005

Steps

StepWhen
Filed publiclyOct 1, 2004
Amended 4 timesNewest Jan 27, 2005
Final prospectus, with the priceJan 31, 2005

Open IPO · From the cover of the final prospectus (424B1) filed Jan 31, 2005

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue409.7K01.00M04.04M4.00M0000
Cost of revenue378.6K21.1K20.3K212.4K21.3K23.9K25.9K28.1K14.1K
Gross profit31.1K-21.1K1.00M-212.4K4.04M-21.3K-23.9K-25.9K-28.1K-14.1K
Research and development6.70M6.80M5.30M8.70M8.10M7.10M5.70M5.30M3.90M3.10M
Selling, general and administrative5.95M5.22M4.98M5.24M5.49M6.45M7.95M9.96M8.80M7.36M
Operating income-13.3M-12.7M-9.90M-14.6M-10.2M-14.2M-14.0M-15.6M-13.0M-10.9M
Depreciation and amortization20.1K21.1K20.3K17.7K26.1K21.3K23.9K25.9K28.1K14.1K
EBITDA-13.3M-12.7M-9.88M-14.6M-10.2M-14.2M-14.0M-15.6M-13.0M-10.9M
Interest expense562.4K84.1K322.8K1.10M0298454
Income before tax-12.0M-11.0M-8.57M-14.1M-10.1M-13.9M-12.9M-14.7M-12.9M-10.9M
Income tax5.99K5.54K3.05K2.82K2.57K-1.65K12.7K5.28K-1.74M3.75K
Net income-12.0M-11.0M-8.57M-14.1M-10.1M-13.9M-12.9M-14.7M-11.2M-10.9M
Earnings per share, basic-0.24-0.23-0.17-0.29-0.21-0.31-0.30-0.36-0.32-0.33
Earnings per share, diluted-0.24-0.23-0.17-0.29-0.21-0.31-0.30-0.36-0.32-0.33

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents30.8M40.4M51.0M18.5M71.4M60.0M63.8M62.3M28.0M24.1M
Short-term investments040.0M000
Receivables00
Inventory00
Current assets31.0M41.1M51.2M59.0M72.0M60.7M64.3M62.8M28.3M24.7M
Property, plant and equipment8.34K25.5K45.8K45.3K57.6K55.7K40.5K53.1K62.9K90.7K
Goodwill9.60M9.60M9.60M9.60M9.60M9.60M9.60M9.60M9.60M9.60M
Total assets45.6M55.9M66.3M74.2M87.4M75.4M79.2M77.2M43.4M39.8M
Accounts payable625.0K1.10M1.00M424.6K402.7K616.6K451.3K616.8K1.52M367.3K
Current liabilities3.80M2.96M3.28M3.19M2.83M2.19M2.23M2.19M2.88M1.63M
Long-term debt00
Total debt194.3K193.8K215.9K681.1K826.6K184.8K399.3K27.2M967.0K
Total liabilities4.02M3.37M3.89M3.91M3.73M4.09M4.31M4.12M4.78M5.28M
Shareholders' equity41.6M52.5M62.4M70.2M83.7M71.3M74.9M73.1M38.6M34.5M
Shares outstanding49.2M49.0M49.0M49.0M49.0M45.0M43.9M42.1M36.5M34.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-9.81M-10.6M-7.43M-12.9M-9.38M-10.8M-9.12M-9.11M-6.92M-6.55M
Capital spending-2.90K-895-21.3K-5.01K-28.7K-36.5K-11.3K-10.2K-10.2K-84.5K
Free cash flow-9.81M-10.6M-7.45M-12.9M-9.41M-10.9M-9.14M-9.12M-6.92M-6.63M
Cash from investing-2.90K-69739.9M-40.0M-28.7K-36.5K-11.3K626.3K-84.5M-84.5K
Cash from financing244.0K032.5B7.92K20.8M7.11M10.6M42.8M10.8M8.67M
Dividends paid00
Share buybacks-112.3K-192.1K27.3K51.0K77.3K87.7K
Change in cash-9.55M-10.6M32.5M-52.9M11.4M-3.76M1.48M34.3M3.87M2.04M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 16, 2026Management or board changeSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeOct 30, 2026Big-stake noticeSEC
4 · Change in ownershipSep 29, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 29, 2026Big-stake noticeSEC
8-K · Current reportSep 28, 2026Material contractSEC
8-K · Current reportSep 2, 2026Current reportSEC
8-K · Current reportAug 19, 2026Management or board changeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
4 · Change in ownershipJun 25, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJun 25, 2026Insider tradeSEC
4 · Change in ownershipJun 25, 2026Insider tradeSEC
8-K · Current reportJun 24, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
PRER14AApr 20, 2026Other filingsSEC
PRE 14A · Preliminary proxy statementApr 17, 2026Meeting noticeSEC
10-K · Annual reportMar 10, 2026Annual reportSEC
8-K · Current reportFeb 20, 2026ResultsSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
424B5 · ProspectusDec 30, 2025Offer documentSEC
8-K · Current reportDec 30, 2025Material contractSEC
EFFECT · Notice that a registration is effectiveDec 12, 2025Other filingsSEC
CORRESP · Letter to the SECDec 9, 2025Other filingsSEC
S-3 · Registration statementDec 5, 2025Offer documentSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
EFFECT · Notice that a registration is effectiveOct 1, 2025Other filingsSEC
CORRESP · Letter to the SECSep 26, 2025Other filingsSEC
UPLOAD · Letter from the SECAug 26, 2025Other filingsSEC
S-1 · Registration statementAug 22, 2025Offer documentSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportJul 31, 2025Material contractSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
8-K · Current reportJun 18, 2025Meeting outcomeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
ARS · Annual report to shareholdersApr 28, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 28, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2025Meeting noticeSEC
8-K · Current reportMar 11, 2025Current reportSEC
10-K · Annual reportFeb 19, 2025Annual reportSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
4 · Change in ownershipJan 10, 2025Insider tradeSEC
4 · Change in ownershipJan 10, 2025Insider tradeSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
8-K · Current reportJun 12, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
8-K · Current reportApr 1, 2024Management or board changeSEC
10-K · Annual reportFeb 15, 2024Annual reportSEC
S-8 POSJan 19, 2024Offer documentSEC
S-8 POSJan 19, 2024Offer documentSEC
S-8 POSJan 19, 2024Offer documentSEC
S-8 POSJan 19, 2024Offer documentSEC
4 · Change in ownershipJan 11, 2024Insider tradeSEC
4 · Change in ownershipJan 11, 2024Insider tradeSEC
4 · Change in ownershipJan 11, 2024Insider tradeSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
10-Q · Quarterly reportAug 9, 2023Quarterly reportSEC
4 · Change in ownershipAug 8, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 8, 2023Insider tradeSEC
8-K · Current reportAug 7, 2023Management or board changeSEC
8-K · Current reportJun 22, 2023Current reportSEC
4 · Change in ownershipJun 15, 2023Insider tradeSEC
4 · Change in ownershipJun 15, 2023Insider tradeSEC
8-K · Current reportJun 13, 2023Meeting outcomeSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
8-K · Current reportApr 26, 2023Management or board changeSEC
ARS · Annual report to shareholdersApr 26, 2023Annual reportSEC
DEFA14A · Additional proxy materialApr 26, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2023Meeting noticeSEC
10-K/A · Annual report, amendedMar 28, 2023Annual reportSEC
10-K · Annual reportFeb 16, 2023Annual reportSEC
4 · Change in ownershipJan 25, 2023Insider tradeSEC
4 · Change in ownershipJan 25, 2023Insider tradeSEC
4 · Change in ownershipJan 25, 2023Insider tradeSEC
4 · Change in ownershipNov 30, 2022Insider tradeSEC
4 · Change in ownershipNov 23, 2022Insider tradeSEC
4 · Change in ownershipNov 21, 2022Insider tradeSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
424B5 · ProspectusSep 30, 2022Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 7, 2022Other filingsSEC
CORRESP · Letter to the SECSep 1, 2022Other filingsSEC
UPLOAD · Letter from the SECAug 31, 2022Other filingsSEC
S-3 · Registration statementAug 26, 2022Offer documentSEC
10-Q · Quarterly reportAug 11, 2022Quarterly reportSEC
SC 13D/A · Big-stake notice, amendedJul 12, 2022Big-stake noticeSEC
3 · Initial statement of ownershipJun 27, 2022Insider tradeSEC
8-K · Current reportJun 21, 2022Management or board changeSEC
4 · Change in ownershipJun 17, 2022Insider tradeSEC
4 · Change in ownershipJun 17, 2022Insider tradeSEC
8-K · Current reportJun 15, 2022Meeting outcomeSEC
S-8 · Registration statement for employee plansMay 13, 2022Offer documentSEC
10-Q · Quarterly reportMay 12, 2022Quarterly reportSEC
DEFA14A · Additional proxy materialApr 26, 2022Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2022Meeting noticeSEC
8-K · Current reportApr 4, 2022Current reportSEC
10-K · Annual reportFeb 16, 2022Annual reportSEC
4 · Change in ownershipJan 31, 2022Insider tradeSEC
4 · Change in ownershipJan 31, 2022Insider tradeSEC
4 · Change in ownershipJan 31, 2022Insider tradeSEC
10-Q · Quarterly reportNov 12, 2021Quarterly reportSEC
4 · Change in ownershipAug 25, 2021Insider tradeSEC
10-Q · Quarterly reportAug 12, 2021Quarterly reportSEC
3 · Initial statement of ownershipAug 10, 2021Insider tradeSEC
8-K · Current reportAug 2, 2021Management or board changeSEC
4 · Change in ownershipJul 23, 2021Insider tradeSEC
8-K · Current reportJul 23, 2021Material contractSEC
SC 13G/A · Big-stake notice, amendedJul 12, 2021Big-stake noticeSEC
4 · Change in ownershipJun 28, 2021Insider tradeSEC
4 · Change in ownershipJun 21, 2021Insider tradeSEC
4 · Change in ownershipJun 21, 2021Insider tradeSEC
8-K · Current reportJun 17, 2021Meeting outcomeSEC
4 · Change in ownershipMay 20, 2021Insider tradeSEC
8-K · Current reportMay 18, 2021Current reportSEC
10-Q · Quarterly reportMay 13, 2021Quarterly reportSEC
8-K · Current reportMay 5, 2021Current reportSEC
DEFA14A · Additional proxy materialApr 27, 2021Meeting noticeSEC
DEF 14A · Proxy statementApr 27, 2021Meeting noticeSEC
4 · Change in ownershipApr 26, 2021Insider tradeSEC
3 · Initial statement of ownershipApr 26, 2021Insider tradeSEC
4 · Change in ownershipMar 15, 2021Insider tradeSEC
4 · Change in ownershipMar 1, 2021Insider tradeSEC
10-K · Annual reportFeb 18, 2021Annual reportSEC
424B3 · ProspectusFeb 12, 2021Offer documentSEC
EFFECT · Notice that a registration is effectiveFeb 11, 2021Other filingsSEC
CORRESP · Letter to the SECFeb 8, 2021Other filingsSEC
UPLOAD · Letter from the SECFeb 5, 2021Other filingsSEC
4 · Change in ownershipFeb 4, 2021Insider tradeSEC
4 · Change in ownershipFeb 4, 2021Insider tradeSEC
4 · Change in ownershipFeb 4, 2021Insider tradeSEC
8-K · Current reportFeb 1, 2021FinancingSEC
S-3 · Registration statementJan 29, 2021Offer documentSEC
SC 13G/A · Big-stake notice, amendedJan 29, 2021Big-stake noticeSEC
3 · Initial statement of ownershipJan 21, 2021Insider tradeSEC
SC 13D · Big-stake noticeJan 21, 2021Big-stake noticeSEC
8-K · Current reportJan 12, 2021Material contractSEC
10-Q · Quarterly reportOct 26, 2020Quarterly reportSEC
4 · Change in ownershipOct 22, 2020Insider tradeSEC
3 · Initial statement of ownershipOct 22, 2020Insider tradeSEC
8-K · Current reportOct 21, 2020Management or board changeSEC
4 · Change in ownershipSep 16, 2020Insider tradeSEC
4 · Change in ownershipAug 7, 2020Insider tradeSEC
10-Q · Quarterly reportJul 28, 2020Quarterly reportSEC
3 · Initial statement of ownershipJun 24, 2020Insider tradeSEC
8-K · Current reportJun 19, 2020Management or board changeSEC
4 · Change in ownershipJun 17, 2020Insider tradeSEC
4 · Change in ownershipJun 17, 2020Insider tradeSEC
8-K · Current reportJun 17, 2020Meeting outcomeSEC
4 · Change in ownershipJun 15, 2020Insider tradeSEC
DEFA14A · Additional proxy materialApr 27, 2020Meeting noticeSEC
DEF 14A · Proxy statementApr 27, 2020Meeting noticeSEC
10-Q · Quarterly reportApr 23, 2020Quarterly reportSEC
8-K · Current reportApr 23, 2020Management or board changeSEC
8-K · Current reportApr 15, 2020Management or board changeSEC
4 · Change in ownershipApr 13, 2020Insider tradeSEC
4 · Change in ownershipApr 13, 2020Insider tradeSEC
4/A · Change in ownership, amendedMar 16, 2020Insider tradeSEC
4 · Change in ownershipMar 13, 2020Insider tradeSEC
4 · Change in ownershipMar 12, 2020Insider tradeSEC
10-K · Annual reportFeb 13, 2020Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 5, 2020Big-stake noticeSEC
4 · Change in ownershipJan 10, 2020Insider tradeSEC
4 · Change in ownershipJan 10, 2020Insider tradeSEC
4 · Change in ownershipJan 10, 2020Insider tradeSEC
8-K · Current reportOct 28, 2019Current reportSEC
8-K · Current reportOct 25, 2019Current reportSEC
10-Q · Quarterly reportOct 24, 2019Quarterly reportSEC
8-K · Current reportAug 23, 2019Material contractSEC
424B5 · ProspectusAug 23, 2019Offer documentSEC
EFFECT · Notice that a registration is effectiveAug 23, 2019Other filingsSEC
CORRESP · Letter to the SECAug 20, 2019Other filingsSEC
UPLOAD · Letter from the SECAug 14, 2019Other filingsSEC
S-3 · Registration statementAug 9, 2019Offer documentSEC
8-K · Current reportJul 26, 2019Current reportSEC
10-Q · Quarterly reportJul 25, 2019Quarterly reportSEC
8-K · Current reportJul 25, 2019Management or board changeSEC
S-8 · Registration statement for employee plansJun 21, 2019Offer documentSEC
4 · Change in ownershipJun 13, 2019Insider tradeSEC
8-K · Current reportJun 11, 2019Meeting outcomeSEC
4 · Change in ownershipJun 11, 2019Insider tradeSEC
4 · Change in ownershipJun 11, 2019Insider tradeSEC
4 · Change in ownershipJun 11, 2019Insider tradeSEC
4 · Change in ownershipMay 14, 2019Insider tradeSEC
DEFA14A · Additional proxy materialMay 1, 2019Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2019Meeting noticeSEC

This page holds 200 of 881 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from MediciNova, Inc.’s releases · as of Nov 10, 2026

Common shares
51,232,668
Fully diluted
51,232,668

Fully diluted

LineSharesAs of
Common shares51,232,668Nov 10, 2026

Share count over time

CountShares
Nov 10, 202651,232,668

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard3.55M6.9%US$5.94MSep 30, 2026
Essex Woodlands Management, Inc.1.11M2.2%US$1.86MSep 30, 2026
BlackRock745K1.5%US$1.25MSep 30, 2026
Goldman Sachs616K1.2%US$1.03MSep 30, 2026
Citigroup Inc549K1.1%US$920KSep 30, 2026
Geode Capital522K1.0%US$875KSep 30, 2026
Renaissance Technologies225K0.44%US$376KSep 30, 2026
State Street194K0.38%US$324KSep 30, 2026
Northern Trust144K0.28%US$240KSep 30, 2026
Jane Street127K0.25%US$213KSep 30, 2026
All 36 holders
HolderSharesOf the companyValueAs of
Two Sigma124K0.24%US$208KSep 30, 2026
BNY78,2770.15%US$131KSep 30, 2026
Schwab71,5060.14%US$120KSep 30, 2026
Bridgeway Capital Management, LLC55,2140.11%US$92,483Sep 30, 2026
SBI Securities Co., Ltd.53,3890.10%US$89,427Sep 30, 2026
Dimensional50,5520.10%US$84,675Sep 30, 2026
Empowered Funds, LLC49,4300.10%US$82,795Sep 30, 2026
UBS36,3260.07%US$60,846Sep 30, 2026
Citadel35,4550.07%US$59,387Sep 30, 2026
Schonfeld Strategic Advisors LLC27,9610.05%US$46,834Sep 30, 2026
Barclays23,7350.05%US$39,756Sep 30, 2026
Qube Research & Technologies Ltd23,6480.05%US$39,610Sep 30, 2026
Susquehanna19,2950.04%US$32,319Sep 30, 2026
XTX Topco Ltd18,6430.04%US$31,227Sep 30, 2026
Aster Capital Management (DIFC) Ltd18,3220.04%US$30,689Sep 30, 2026
Jump Financial, LLC17,7300.03%US$29,698Sep 30, 2026
HighTower Advisors, LLC10,0000.02%US$16,750Sep 30, 2026
Focus Advisor Solutions, LLC10,0000.02%US$16,750Sep 30, 2026
Hantz Financial Services, Inc.4,232<0.01%US$7,000Sep 30, 2026
Morgan Stanley2,314<0.01%US$3,876Sep 30, 2026
Group One Trading LLC1,893<0.01%US$3,171Sep 30, 2026
Simplex Trading, LLC1,217<0.01%US$2,038Sep 30, 2026
Northwestern Mutual Wealth Management Co305<0.01%US$511Sep 30, 2026
Caitong International Asset Management Co., Ltd90<0.01%US$151Sep 30, 2026
Osaic Holdings, Inc.66<0.01%US$110Sep 30, 2026
Larson Financial Group LLC5<0.01%US$8Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund609K1.2%US$804KJun 30, 2026
Fidelity Extended Market Index Fund255K0.50%US$347KMay 31, 2026
iShares Micro-Cap ETF159K0.31%US$210KJun 30, 2026
Fidelity Total Market Index Fund87,5750.17%US$119KMay 31, 2026
Schwab Total Stock Market Index Fund71,5060.14%US$95,103Jul 31, 2026
Fidelity Series Total Market Index Fund68,4060.13%US$93,032May 31, 2026
Ultra-Small Company Market Fund50,2470.10%US$66,326Jun 30, 2026
Fidelity Nasdaq Composite Index Fund25,9660.05%US$35,314May 31, 2026
Small Cap Core Fund13,8940.03%US$18,340Jun 30, 2026
1290 VT Micro Cap Portfolio10,5250.02%US$13,893Jun 30, 2026
All 14 holders
HolderSharesOf the companyValueAs of
LVIP Dimensional U.S. Core Equity 2 Fund6,6930.01%US$8,835Jun 30, 2026
AST Small-Cap Equity Portfolio4,930<0.01%US$6,508Jun 30, 2026
JNL/DFA U.S. Small Cap Fund3,000<0.01%US$3,960Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund100<0.01%US$132Jun 30, 2026

Insider trades

TradeTradeSharesPriceValueDate
3D Opportunity Master Fund
Other: Formerly 10% Owner
Sale640,000USD 2.70US$1.73MSep 25, 2026

Big stakes

StakeStakeSharesDateFiling
3D Investment Partners Pte. Ltd.9.90%4.86MSep 25, 2026Schedule 13D
Vanguard Capital Management LLC7.20%3.55MSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alan W. Dunton
Other companies: CorMedix Inc. (Director · Since at least Mar 1, 2019); Palatin Technologies, Inc. (Director · Since at least Jun 22, 2011); Oragenics Inc. (Director · Since at least Apr 1, 2011); Adams Respiratory Therapeutics Inc (Director · Nov 8, 2006 – Jan 29, 2008 · Past); Gyre Therapeutics, Inc. (Director · Oct 18, 2006 – Aug 14, 2015 · Past)
Director · May 11, 2006 – Jun 11, 2010 · Past
Jeff Himawan
Other companies: Gyre Therapeutics, Inc. (Director · Aug 20, 2015 – Aug 20, 2015 · Past); Horizon Pharma PLC (Director · Jul 28, 2011 – May 3, 2018 · Past); Iomai Corp (Director · Jan 25, 2006 – Oct 25, 2006 · Past)
Director · Jan 9, 2006 – Jun 14, 2011 · Past
Nicole Lemerond
Other companies: GeoVax Labs, Inc. (Director · Since at least Aug 31, 2022); InMed Pharmaceuticals Inc. (Director · Since at least Aug 8, 2022)
Director · Since at least Aug 4, 2023
Ryan Selhorn
Other companies: Aytu BioPharma, Inc. (Chief Financial Officer · Since at least Nov 11, 2024)
Chief Financial Officer · Mar 31, 2016 – Mar 31, 2016 · Past
David H. CreanPh.D.Chief Business OfficerMediciNova · Oct 6, 2026 – Nov 5, 2026 · Past
Douglas PaulinChief Financial Officer · Aug 1, 2021 – Aug 1, 2021 · Past
Edward C Stepanow JrChief Financial Officer · Jun 19, 2020 – Jun 19, 2020 · Past
Geoffrey OBrienVice President · Oct 15, 2013 – Jan 9, 2024 · Past
Hideki NagaoDirector · Since at least Jan 4, 2006
Kazuko MatsudaMember of the Board of Directors, Senior Vice President, Chief Medical Officer, Representative, Tokyo Office · Since at least Jan 9, 2024
All 15 people
PersonSeat
Kirk William JohnsonChief Scientific Officer · Jun 14, 2012 – May 13, 2013 · Past
Kousuke NakataDirector · Jan 15, 2014 – Jan 15, 2014 · Past
Masatsune OkajimaVP and Head of Japanese Office · Jan 18, 2017 – Feb 28, 2019 · Past
Yoshio IshizakaDirector · Apr 8, 2014 – Jun 10, 2019 · Past
Yuichi IwakiExecutive Chairman of the Board, President and Chief Executive Officer, Founder · Since at least Sep 24, 2026

Open People

Log in to ask 6ix AI your own questions about MediciNova, Inc.